10 employees
Alzinova AB operates as a biotechnology company engaged in drug discovery research for Alzheimer’s disease.
2011
$53K
from 1 investors over 1 rounds
Alzinova AB raised $53K on March 1, 2017
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)